Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can continuing benzodiazepine use be predicted?

C Ineke Neutel1, Wikke Walop, Scott B Patten

  • 1Health Intelligence, SCO Health Service Inc., Ottawa, Ontario. ineutel@scohs.on.ca

The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|January 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depression screening tool accuracy individual participant data meta-analyses: data contribution was associated with multiple factors.

Journal of clinical epidemiology·2023
Same author

Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2023
Same author

Transition readiness of youth with co-occurring chronic health and mental health conditions: A mixed methods study.

Health expectations : an international journal of public participation in health care and health policy·2023
Same author

Identifying Unique Subgroups of High-Cost Patients With Schizophrenia: A Population-Based Study Using Latent Class Analysis.

Health services insights·2023
Same author

Surveillance of Child and Youth Mental Disorders and Associated Service Use in Canada.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2023
Same author

Assessment of differential item functioning of the PHQ-9, HADS-D and PROMIS-depression scales in persons with and without multiple sclerosis.

Journal of psychosomatic research·2023
Same journal

A review of substance abuse monitoring in a social services context: a primer for child protection workers.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique·2010
Same journal

Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique·2010
Same journal

The impact of an ADHD co-morbidity on the diagnosis of FASD.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique·2010
Same journal

Profile of the first 1,400 patients receiving diagnostic evaluations for fetal alcohol spectrum disorder at the Washington State Fetal Alcohol Syndrome Diagnostic & Prevention Network.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique·2010
Same journal

Managing fetal alcohol spectrum disorder in the public school system: a needs assessment pilot.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique·2010
Same journal

Acute intravascular haemolysis associated with intravenous administration of meropenem in a sixty four year old man.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique·2010
See all related articles

Previous benzodiazepine (BZD) use is the strongest predictor of continued BZD use. Health status and concurrent antidepressant use also predict initial BZD use, but not long-term patterns.

Area of Science:

  • Pharmacology
  • Public Health
  • Epidemiology

Background:

  • Benzodiazepines (BZDs) are commonly prescribed medications.
  • Understanding predictors of BZD use and continuation is crucial for public health.
  • Long-term BZD use can lead to dependence and adverse health outcomes.

Purpose of the Study:

  • To identify characteristics associated with initial benzodiazepine (BZD) use.
  • To determine predictors of continued BZD use over a two-year period.
  • To inform clinical practice regarding BZD prescribing.

Main Methods:

  • A longitudinal study of 11,624 Canadians surveyed two years apart.
  • Logistic regression analysis was used to identify predictors.
  • Data included demographics, health status, chronic conditions, and medication use.

Related Experiment Videos

Main Results:

  • Initial BZD use was associated with antidepressant use, poor health, pain, and chronic conditions.
  • Over half (53.4%) of initial BZD users continued use two years later.
  • Previous BZD use was the only significant predictor of continued use; other factors were not predictive.

Conclusions:

  • Previous benzodiazepine (BZD) use is the primary predictor of continued use.
  • Prescribers should be aware of the high likelihood of continued BZD use.
  • Further research into BZD half-life and continued use is warranted.